Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

6drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: pazopanib ×

pazopanib

This drug is selected. Its supporting articles are shown below.

pazopanib3

Articles mentioning pazopanib

3 articles · page 1 of 1

Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions

bmjonc · full text · 2026-01-28 · 4 matching annotations

97.7%

pembrolizumab bortezomib crizotinib pembrolizumab35 sunitinib dasatinib

…umab) are often used in ovarian and cervical cancers. ICIs (eg, pembrolizumab) are effective in mismatch repair-deficient endometrial cancer …

5PSQ-053 Implementation of a personalised telepharmacy model in oncological patients

ejhpharm · abstract · 2026-03-18 · 1 matching annotations

99.3%

enzalutamide apalutamide pazopanib abiraterone olaparib sunitinib capecitabine imatinib osimertinib abemaciclib+8 more

… 5% had ovarian, renal or lung cancer. The involved drugs were: enzalutamide(25), apalutamide(14), abiraterone (9), abemaciclib(6), capecita…

523 Median OS of 21.5 months among 44 patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma treated with mecbotamab vedotin, an AXL-targeting ADC

jitc · abstract · 2025-11-04 · 1 matching annotations

91.1%

mecbotamab vedotin eribulin Mec-V trabectedin pazopanib BA3011 leiomyosarcoma

…cancer (NSCLC) patients with mutated KRAS in a phase 2 trial of mecbotamab vedotin (CAB-AXL-ADC). Presented at: European Lung Cancer Congress; 202…